Figure 3.

(A). Postoperative survival. Of all 124 patients, 36 patients died <3 years after surgery, whereas the other 88 patients survived ≥3 years after surgery. The 3-year and 5-year survival rates were 70% and 60%, respectively. The estimated median survival time was 93 months. The tick marks indicate the last date of follow-up. (B). Postoperative survival. The 3-year and 5-year survival rates of the patients with kidney cancer, thyroid cancer, low-grade sarcoma, lung cancer, and breast cancer were 77% and 61%, 93% and 86%, 77% and 69%, 62% and 62%, and 67% and 67%, respectively. The tick marks indicate the last date of follow-up.